Literature DB >> 7488076

Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor.

B Q Li1, M H Wang, H F Kung, C Ronsin, R Breathnach, E J Leonard, T Kamata.   

Abstract

Macrophage-stimulating protein (MSP) is a chemotactic factor that activates the receptor tyrosine kinase RON. The involvement of Ras in MSP-induced signal transduction was investigated. Here we demonstrate that, in RON-transfected MDCK cells, an active GTP-bound form of Ras was rapidly accumulated by MSP treatment and the Ras-guanine nucleotide exchange activity in SOS immunoprecipitates was concomitantly increased. GAP activity was not changed under the same conditions used. Furthermore, the SH2 domain of adaptor protein GRB2, but not Shc, associated with the activated RON-beta chain, and GRB2-SOS complexes translocated from the cytosol to the membrane upon MSP treatment. These results strongly suggest that MSP activates Ras through RON, and that MSP-induced activation of Ras might be controlled by both the enhancement of catalytic exchange activity of SOS and its translocation to the membrane where its target Ras is localized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488076     DOI: 10.1006/bbrc.1995.2598

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Amelioration of central cardiovascular regulatory dysfunction by tropomyocin receptor kinase B in a mevinphos intoxication model of brain stem death.

Authors:  S H H Chan; J Y H Chan; K S Hsu; F C H Li; E Y H Sun; W L Chen; A Y W Chang
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 2.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

Review 3.  MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

4.  Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin.

Authors:  S Brunelleschi; L Penengo; L Lavagno; C Santoro; D Colangelo; I Viano; G Gaudino
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

5.  Constitutive activation of the RON gene promotes invasive growth but not transformation.

Authors:  M M Santoro; C Collesi; S Grisendi; G Gaudino; P M Comoglio
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

Review 6.  Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

Authors:  Purnima K Wagh; Belinda E Peace; Susan E Waltz
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

Review 7.  Ron receptor tyrosine kinase signaling as a therapeutic target.

Authors:  Nancy M Benight; Susan E Waltz
Journal:  Expert Opin Ther Targets       Date:  2012-07-26       Impact factor: 6.902

8.  Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.

Authors:  Jing Wang; Ashwani Rajput; Julie L C Kan; Rebecca Rose; Xiao-Qiong Liu; Karen Kuropatwinski; Jennie Hauser; Alexander Beko; Ivan Dominquez; Elizabeth A Sharratt; Lisa Brattain; Charles Levea; Feng-Lei Sun; David M Keane; Neil W Gibson; Michael G Brattain
Journal:  J Biol Chem       Date:  2009-02-18       Impact factor: 5.157

9.  Catalytic activity of the mouse guanine nucleotide exchanger mSOS is activated by Fyn tyrosine protein kinase and the T-cell antigen receptor in T cells.

Authors:  B Li; M Subleski; N Fusaki; T Yamamoto; T Copeland; G L Princler; H Kung; T Kamata
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

Review 10.  Ron-receptor tyrosine kinase in tumorigenesis and metastasis.

Authors:  Mike A Leonis; Megan N Thobe; Susan E Waltz
Journal:  Future Oncol       Date:  2007-08       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.